Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000802652 | SCV000942493 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000991930 | SCV001143805 | uncertain significance | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000991930 | SCV001822419 | likely benign | not provided | 2019-04-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002386432 | SCV002702910 | uncertain significance | Inborn genetic diseases | 2020-07-27 | criteria provided, single submitter | clinical testing | The p.A4551T variant (also known as c.13651G>A), located in coding exon 76 of the DYNC1H1 gene, results from a G to A substitution at nucleotide position 13651. The alanine at codon 4551 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Ce |
RCV000991930 | SCV004010329 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | DYNC1H1: BP4, BS2 |
Service de Génétique Moléculaire, |
RCV001255800 | SCV001432414 | likely benign | Intellectual disability, autosomal dominant 13 | no assertion criteria provided | clinical testing |